Statistics
Publications
22
Citations
2K
H-Index
20
Active since
2006
Stephen J. Atkinson is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, drug discovery, and biochemistry.
Publications per year
2006–2024
22
22
Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation
Huw D. Lewis, John Liddle, Jim Coote et al. · Nature Chemical Biology · 2015 · 717 citations · Full text
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation
Omer Gilan, Inmaculada Rioja, Kathy Knezevic et al. · Science · 2020 · 411 citations · Full text
1–5 of 22